Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs Citrate Anticoagulation in CRRT for AKI
NCT06646328Phase 4Terminated
- Start
- Jun 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trisodium citrate in acute kidney injury (AKI) (2 arms). Primary endpoint: Recovery of renal function at 20 days. Started Jun 2018; status: terminated.
02
Drugs
trisodium citrate
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06646328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06646328.